why choose us

First received: August 28, 2023

Clinical Trial: Study of Predictors of Clinical Outcomes in Patients With HR+ and HER2-low/Negative Breast Cancer

Study Status: ACTIVE_NOT_RECRUITING

Recruit Status: ACTIVE_NOT_RECRUITING

Condition: Hormone-receptor-positive Breast Cancer

Study Type: OBSERVATIONAL


Official Title: Identify Predictors of Clinical Outcomes in Real-world Patients With HR+ and HER2-low/Negative Breast Cancer Treated With Neoadjuvant Chemotherapy or Endocrine Therapy

Brief Summary: There is a lack of data on clinical and patient factors that are associated with poor survival in patients with HR+ and HER2-low/negative breast cancer treated with neoadjuvant chemotherapy or endocrine therapy.This retrospective, non-interventional study is designed to assess the predictors of clinical outcomes in this patient population.No study drug will be provided as part of this study protocol.

Read more